phase 2_completion
saveRegeneron Pharmaceuticals Inc — cemiplimab (Phase II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Adenocarcinoma, Colon Cancer, Colorectal Cancer
Therapy area: Oncology. Indication: Adenocarcinoma, Colon Cancer, Colorectal Cancer